GENTAUR Belgium BVBA BE0473327336 Voortstraat 49, 1910 Kampenhout BELGIUM Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc,Logistics 547 Yurok Circle, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, [email protected]

Parkinsons Disease Pathway

pathways : Parkinsons Disease Pathway pathways:

Fullview (zoomIn)

Related Pathways to "Parkinsons Disease Pathway" content :


Related Genes to "Parkinsons Disease Pathway" content :

preload


Flag U.S.AEN | Flag FranceFR | Flag U.S.AUS | Flag GermanyDE | Flag PolandPL
Flag NetherlandsNL | Flag BelgiumBE | Flag UKUK | Flag BugariaBG
Quick order!
Enter catalog number :


Search in Google:

google

Share this page:
share on twitter rss feedsfacebookgoogle gentaur


Categories :

Gentaur; yes we can

Related products :

Catalog number Product name Quantity
IPLA-PARK-SER Disease State Samples: Single Donor Human Parkinsons Serum 1ml
IPLA-PARK Disease State Samples: Single Donor Human Parkinsons Plasma 1ml
IPLA-PARK-1ml Single Donor Human Parkinsons Plasma 1ml 1ml
IPLA-PARK-SER-1ml Single Donor Human Parkinsons Serum 1ml 1ml
IPLA-PARK-SER-1ml Single Donor Human Parkinsons Serum 1ml
IPLA-PARK-1ml Single Donor Human Parkinsons Plasma 1ml
CS-1003-04 miRNA Pathway Profiling Cell Array (MAPK Ras Pathway, 8 Plates) 8 X 96
CS-1003-05 miRNA Pathway Profiling Cell Array (Wnt b-catenin Pathway, 8 Plates) 8 X 96
CS-1003-03 miRNA Pathway Profiling Cell Array (Notch Pathway, 8 Plates) 8 X 96
CS-1003-02 miRNA Pathway Profiling Cell Array (NFkB Pathway, 8 Plates) 8 X 96
CS-1004-01 miRNA Pathway Profiling Cell Array (TGFb Pathway, 4 Plates) 4 X 96
CS-1004-03 miRNA Pathway Profiling Cell Array (Notch Pathway, 4 Plates) 4 X 96
CS-1004-04 miRNA Pathway Profiling Cell Array (MAPK Ras Pathway, 4 Plates) 4 X 96
CS-1004-05 miRNA Pathway Profiling Cell Array (Wnt b-catenin Pathway, 4 Plates) 4 X 96
CS-1004-02 miRNA Pathway Profiling Cell Array (NFkB Pathway, 4 Plates) 4 X 96
CS-1003-01 miRNA Pathway Profiling Cell Array (TGFb Pathway, 8 Plates) 8 X 96
30-110 CBS is involved in the transsulfuration pathway. The first step of this pathway, from homocysteine to cystathionine, is catalyzed by this protein. CBS deficiency can cause homocystinuria which affects 0.1 mg
29-978 Alzheimer's disease (AD) patients with an inherited form of the disease carry mutations in the presenilin proteins (PSEN1 or PSEN2) or the amyloid precursor protein (APP). These disease-linked mutatio 0.05 mg
30-188 Biosynthesis of coenzyme A (CoA) from pantothenic acid (vitamin B5) is an essential universal pathway in prokaryotes and eukaryotes. PPCDC, one of the last enzymes in this pathway, converts phosphopan 0.1 mg
30-888 The major pathway for the biosynthesis of phosphatidylcholine occurs via the CDP-choline pathway. CHKA is the initial enzyme in the sequence and may play a regulatory role. It also catalyzes the phosp 0.05 mg
26-070 Tryptophan 2,3-dioxygenase (EC 1.13.11.11) plays a role in catalyzing the first and rat-limiting step in the kynurenine pathway, the major pathway of tryptophan metabolism. 0.05 mg
30-106 Tryptophan 2,3-dioxygenase (EC 1.13.11.11) plays a role in catalyzing the first and rat-limiting step in the kynurenine pathway, the major pathway of tryptophan metabolism. 0.05 mg
CS-1004-05 Frozen cell: miRNA Pathway Profiling Cell Array (Wnt_b-catenin Pathway, 4 Plates) 4 X 96
CS-1003-05 Frozen cell: miRNA Pathway Profiling Cell Array (Wnt_b-catenin Pathway, 8 Plates) 8 X 96
CS-1003-03 Frozen cell: miRNA Pathway Profiling Cell Array (Notch Pathway, 8 Plates) 8 X 96

Pathways :

WP2371: Parkinsons Disease Pathway
WP1147: Pentose Phosphate Pathway
WP400: p38 MAPK Signaling Pathway
WP1299: ErbB signaling pathway
WP539: Wnt Signaling Pathway NetPath
WP1381: G13 Signaling Pathway
WP754: Wnt Signaling Pathway NetPath
WP2018: RANKL/RANK Signaling Pathway
WP858: IL-6 Signaling Pathway
WP1770: One carbon metabolism and related pathways
WP229: Irinotecan Pathway
WP946: Delta-Notch Signaling Pathway
WP1: Statin Pathway
WP2412: New Pathway
WP1094: IL-6 Signaling Pathway
WP366: TGF beta Signaling Pathway
WP118: IL-7 Signaling Pathway
WP480: T Cell Receptor Signaling Pathway
WP1348: Androgen Receptor Signaling Pathway
WP668: Octadecanoid Pathway
WP17: daf-2 or insulin signaling pathway
WP801: ACE Inhibitor Pathway
WP2139: Practical assignment pathway
WP911: Pentose Phosphate Pathway
WP704: Methylation Pathways

Related Genes :
[DTX47 EDS5 IAP1 SCORD3 SID1 At4g39030 F19H22.130] Protein DETOXIFICATION 47, chloroplastic (AtDTX47) (Multidrug and toxic compound extrusion protein 47) (MATE protein 47) (Protein ENHANCED DISEASE SUSCEPTIBILITY 5) (Protein EDS5) (Protein IMPORTANT FOR THE ARR PATHWAY 1) (Protein IAP1) (Protein SALICYLIC ACID INDUCTION DEFICIENT 1) (Protein SID1) (Protein SUSCEPTIBLE TO CORONATINE-DEFICIENT PST DC3000 3) (Protein SCORD3)
[PRKN PARK2] E3 ubiquitin-protein ligase parkin (Parkin) (EC 2.3.2.31) (Parkin RBR E3 ubiquitin-protein ligase) (Parkinson juvenile disease protein 2) (Parkinson disease protein 2)
[PKD2 TRPP2] Polycystin-2 (PC2) (Autosomal dominant polycystic kidney disease type II protein) (Polycystic kidney disease 2 protein) (Polycystwin) (R48321) (Transient receptor potential cation channel subfamily P member 2)
[RPS4 At5g45250 K9E15.1] Disease resistance protein RPS4 (Resistance to Pseudomonas syringae 4) (TIR-NBS-LRR class disease resistance protein)
[COL17A1 BP180 BPAG2] Collagen alpha-1(XVII) chain (180 kDa bullous pemphigoid antigen 2) (Bullous pemphigoid antigen 2) [Cleaved into: 120 kDa linear IgA disease antigen (120 kDa linear IgA dermatosis antigen) (Linear IgA disease antigen 1) (LAD-1); 97 kDa linear IgA disease antigen (97 kDa linear IgA bullous dermatosis antigen) (97 kDa LAD antigen) (97-LAD) (Linear IgA bullous disease antigen of 97 kDa) (LABD97)]
[RRS1 RCH2 RRS1-S RSH4 SLH1 WRKY52 At5g45260/At5g45270 K9E15.2/K9E15.3] Disease resistance protein RRS1 (Disease resistance protein RCH2) (Disease resistance protein SLH1) (Probable WRKY transcription factor 52) (Protein RPS4-homolog) (Protein SENSITIVE TO LOW HUMIDITY 1) (Resistance to Colletotrichum higginsianum 2 protein) (Resistance to Ralstonia solanacearum 1 protein) (WRKY DNA-binding protein 52)
[APP A4 AD1] Amyloid-beta precursor protein (APP) (ABPP) (APPI) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta A4 protein) (Cerebral vascular amyloid peptide) (CVAP) (PreA4) (Protease nexin-II) (PN-II) [Cleaved into: N-APP; Soluble APP-alpha (S-APP-alpha); Soluble APP-beta (S-APP-beta); C99 (Beta-secretase C-terminal fragment) (Beta-CTF); Amyloid-beta protein 42 (Abeta42) (Beta-APP42); Amyloid-beta protein 40 (Abeta40) (Beta-APP40); C83 (Alpha-secretase C-terminal fragment) (Alpha-CTF); P3(42); P3(40); C80; Gamma-secretase C-terminal fragment 59 (Amyloid intracellular domain 59) (AICD-59) (AID(59)) (Gamma-CTF(59)); Gamma-secretase C-terminal fragment 57 (Amyloid intracellular domain 57) (AICD-57) (AID(57)) (Gamma-CTF(57)); Gamma-secretase C-terminal fragment 50 (Amyloid intracellular domain 50) (AICD-50) (AID(50)) (Gamma-CTF(50)); C31]
[PARK7] Protein/nucleic acid deglycase DJ-1 (EC 3.1.2.-) (EC 3.5.1.-) (EC 3.5.1.124) (Maillard deglycase) (Oncogene DJ1) (Parkinson disease protein 7) (Parkinsonism-associated deglycase) (Protein DJ-1) (DJ-1)
[NDP EVR2] Norrin (Norrie disease protein) (X-linked exudative vitreoretinopathy 2 protein)
[NOD2 CARD15 IBD1] Nucleotide-binding oligomerization domain-containing protein 2 (Caspase recruitment domain-containing protein 15) (Inflammatory bowel disease protein 1)
[VHL] von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL)
[PAD4 EDS9 At3g52430 F22O6.190] Lipase-like PAD4 (EC 2.3.1.-) (Protein ENHANCED DISEASE SUSCEPTIBILITY 9) (Protein PHYTOALEXIN DEFICIENT 4) (AtPAD4)
[PKD1] Polycystin-1 (PC1) (Autosomal dominant polycystic kidney disease 1 protein)
[ATXN3 ATX3 MJD MJD1 SCA3] Ataxin-3 (EC 3.4.19.12) (Machado-Joseph disease protein 1) (Spinocerebellar ataxia type 3 protein)
[Park7] Protein/nucleic acid deglycase DJ-1 (EC 3.1.2.-) (EC 3.5.1.-) (EC 3.5.1.124) (Maillard deglycase) (Parkinson disease protein 7 homolog) (Parkinsonism-associated deglycase) (Protein DJ-1) (DJ-1)
[App] Amyloid-beta A4 protein (ABPP) (APP) (Alzheimer disease amyloid A4 protein homolog) (Amyloid precursor protein) (Amyloid-beta precursor protein) (Amyloidogenic glycoprotein) (AG) [Cleaved into: N-APP; Soluble APP-alpha (S-APP-alpha); Soluble APP-beta (S-APP-beta); C99 (APP-C99) (Beta-secretase C-terminal fragment) (Beta-CTF); Amyloid-beta protein 42 (Abeta42) (Beta-APP42); Amyloid-beta protein 40 (Abeta40) (Beta-APP40); C83 (Alpha-secretase C-terminal fragment) (Alpha-CTF); P3(42); P3(40); C80; Gamma-secretase C-terminal fragment 59 (APP-C59) (Amyloid intracellular domain 59) (AID(59)) (Gamma-CTF(59)); Gamma-secretase C-terminal fragment 57 (APP-C57) (Amyloid intracellular domain 57) (AID(57)) (Gamma-CTF(57)); Gamma-secretase C-terminal fragment 50 (Amyloid intracellular domain 50) (AID(50)) (Gamma-CTF(50)); C31]
[EDR1 STY10 At1g08720 F22O13.20] Serine/threonine-protein kinase EDR1 (EC 2.7.11.1) (MAPKK kinase EDR1) (Protein ENHANCED DISEASE RESISTANCE 1) (AtEDR1) (Serine/threonine/tyrosine-protein kinase 10)
[Vhl Vhlh] von Hippel-Lindau disease tumor suppressor (pVHL)
[Pkd2 TRPP2] Polycystin-2 (Polycystic kidney disease 2 protein homolog) (Transient receptor potential cation channel subfamily P member 2)
[NCF1 NOXO2 SH3PXD1A] Neutrophil cytosol factor 1 (NCF-1) (47 kDa autosomal chronic granulomatous disease protein) (47 kDa neutrophil oxidase factor) (NCF-47K) (Neutrophil NADPH oxidase factor 1) (Nox organizer 2) (Nox-organizing protein 2) (SH3 and PX domain-containing protein 1A) (p47-phox)
[Ift88 Tg737 Tg737Rpw TgN737Rpw Ttc10] Intraflagellar transport protein 88 homolog (Recessive polycystic kidney disease protein Tg737) (Tetratricopeptide repeat protein 10) (TPR repeat protein 10) (TgN(Imorpk)737Rpw)
[Ndp Ndph] Norrin (Norrie disease protein homolog)
[SUMM2 At1g12280 F5O11.3] Disease resistance protein SUMM2 (Disease resistance protein At1g12280) (Protein SUPPRESSOR OF MKK1 MKK2 2)
[App] Amyloid-beta A4 protein (ABPP) (APP) (Alzheimer disease amyloid A4 protein homolog) (Amyloid precursor protein) (Amyloid-beta precursor protein) (Amyloidogenic glycoprotein) (AG) [Cleaved into: N-APP; Soluble APP-alpha (S-APP-alpha); Soluble APP-beta (S-APP-beta); C99 (Beta-secretase C-terminal fragment) (Beta-CTF); Amyloid-beta protein 42 (Abeta42) (Beta-APP42); Amyloid-beta protein 40 (Abeta40) (Beta-APP40); C83 (Alpha-secretase C-terminal fragment) (Alpha-CTF); P3(42); P3(40); C80; Gamma-secretase C-terminal fragment 59 (Gamma-CTF(59)); Gamma-secretase C-terminal fragment 57 (Gamma-CTF(57)); Gamma-secretase C-terminal fragment 50 (Gamma-CTF(50)); C31]
[Htt Hd Hdh] Huntingtin (Huntington disease protein homolog) (HD protein homolog) [Cleaved into: Huntingtin, myristoylated N-terminal fragment]
[IGHG3] Immunoglobulin heavy constant gamma 3 (HDC) (Heavy chain disease protein) (Ig gamma-3 chain C region)
[Vhl] von Hippel-Lindau disease tumor suppressor (pVHL)
[atx-3 F28F8.6] Ataxin-3 homolog (EC 3.4.19.12) (Machado-Joseph disease-like protein)
[APP QccE-15949] Amyloid-beta A4 protein (ABPP) (APP) (Alzheimer disease amyloid A4 protein homolog) (Amyloid precursor protein) (Amyloid-beta precursor protein) [Cleaved into: N-APP; Soluble APP-alpha (S-APP-alpha); Soluble APP-beta (S-APP-beta); C99 (Beta-secretase C-terminal fragment) (Beta-CTF); Amyloid-beta protein 42 (Abeta42) (Beta-APP42); Amyloid-beta protein 40 (Abeta40) (Beta-APP40); C83 (Alpha-secretase C-terminal fragment) (Alpha-CTF); P3(42); P3(40); C80; Gamma-secretase C-terminal fragment 59 (Gamma-CTF(59)); Gamma-secretase C-terminal fragment 57 (Gamma-CTF(57)); Gamma-secretase C-terminal fragment 50 (Gamma-CTF(50)); C31]
[ATP7A MC1 MNK] Copper-transporting ATPase 1 (EC 7.2.2.8) (Copper pump 1) (Menkes disease-associated protein)
Bibliography :
[31604427] Quantifying mechanisms in neurodegenerative diseases (NDDs) using candidate mechanism perturbation amplitude (CMPA) algorithm.
[31593492] Identification of Biomolecular Information in Rotenone-Induced Cellular Model of Parkinson's Disease by Public Microarray Data Analysis.
[31591470] The necroptosis machinery mediates axonal degeneration in a model of Parkinson disease.
[31586624] Apelin-36 Mediates Neuroprotective Effects by Regulating oxidative stress, autophagy and apoptosis in MPTP-induced Parkinson's Disease model mice.
[31584222] Exercise increases caudate dopamine release and ventral striatal activation in Parkinson's disease.
[31535659] Effect of stromal cell-derived factor-1/CXCR4 axis in neural stem cell transplantation for Parkinson's disease.
[31520529] Salidroside Protects Dopaminergic Neurons by Regulating the Mitochondrial MEF2D-ND6 Pathway in the MPTP/MPP -Induced Model of Parkinson's Disease.
[31513985] Long non-coding RNA Mirt2 prevents TNF-α-triggered inflammation via the repression of microRNA-101.
[31506635] RIP1/RIP3/MLKL mediates dopaminergic neuron necroptosis in a mouse model of Parkinson disease.
[31502290] Aberrant features of in vivo striatal dynamics in Parkinson's disease.